Armistice Master Fund LTV investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 30, 2022
Aterian
|
Post-IPO Equity | $20M | Consumer Goods | Yes |
Jul 22, 2022
Addex Therapeutics
|
Post-IPO Equity | $4.20M | Biotechnology | Yes |
Armistice Master Fund LTV has had 2 exits. Armistice Master Fund LTV most notable exits include Aterian , Addex Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 12, 2019 | Aterian | IPO | Consumer Goods | Detail |
May 21, 2007 | Addex Therapeutics | IPO | Biotechnology | Detail |